Cargando…

Long-lasting successful dissemination of resistance to oxazolidinones in MDR Staphylococcus epidermidis clinical isolates in a tertiary care hospital in France

OBJECTIVES: Patient- and procedure-related changes in modern medicine have turned CoNS into one of the major nosocomial pathogens. Treatments of CoNS infections are challenging owing to the large proportion of MDR strains and oxazolidinones often remain the last active antimicrobial molecules. Here,...

Descripción completa

Detalles Bibliográficos
Autores principales: Dortet, Laurent, Glaser, Philippe, Kassis-Chikhani, Najiby, Girlich, Delphine, Ichai, Philippe, Boudon, Marc, Samuel, Didier, Creton, Elodie, Imanci, Dilek, Bonnin, Rémy, Fortineau, Nicolas, Naas, Thierry
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5890688/
https://www.ncbi.nlm.nih.gov/pubmed/29092052
http://dx.doi.org/10.1093/jac/dkx370
_version_ 1783312908361400320
author Dortet, Laurent
Glaser, Philippe
Kassis-Chikhani, Najiby
Girlich, Delphine
Ichai, Philippe
Boudon, Marc
Samuel, Didier
Creton, Elodie
Imanci, Dilek
Bonnin, Rémy
Fortineau, Nicolas
Naas, Thierry
author_facet Dortet, Laurent
Glaser, Philippe
Kassis-Chikhani, Najiby
Girlich, Delphine
Ichai, Philippe
Boudon, Marc
Samuel, Didier
Creton, Elodie
Imanci, Dilek
Bonnin, Rémy
Fortineau, Nicolas
Naas, Thierry
author_sort Dortet, Laurent
collection PubMed
description OBJECTIVES: Patient- and procedure-related changes in modern medicine have turned CoNS into one of the major nosocomial pathogens. Treatments of CoNS infections are challenging owing to the large proportion of MDR strains and oxazolidinones often remain the last active antimicrobial molecules. Here, we have investigated a long-lasting outbreak (2010–13) due to methicillin- and linezolid-resistant (LR) CoNS (n = 168), involving 72 carriers and 49 infected patients. METHODS: Antimicrobial susceptibilities were tested by the disc diffusion method and MICs were determined by broth microdilution or Etest. The clonal relationship of LR Staphylococcus epidermidis (LRSE) was first determined using a semi-automated repetitive element palindromic PCR (rep-PCR) method. Then, WGS was performed on all cfr-positive LRSE (n = 30) and LRSE isolates representative of each rep-PCR-defined clone (n = 17). Self-transferability of cfr-carrying plasmids was analysed by filter-mating experiments. RESULTS: This outbreak was caused by the dissemination of three clones (ST2, ST5 and ST22) of LRSE. In these clones, linezolid resistance was caused by (i) mutations in the chromosome-located genes encoding the 23S RNA and L3 and L4 ribosomal proteins, but also by (ii) the dissemination of two different self-conjugative plasmids carrying the cfr gene encoding a 23S RNA methylase. By monitoring linezolid prescriptions in two neighbouring hospitals, we highlighted that the spread of LR-CoNS was strongly associated with linezolid use. CONCLUSIONS: Physicians should be aware that plasmid-encoded linezolid resistance has started to disseminate among CoNS and that rational use of oxazolidinones is critical to preserve these molecules as efficient treatment options for MDR Gram-positive pathogens.
format Online
Article
Text
id pubmed-5890688
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-58906882018-04-13 Long-lasting successful dissemination of resistance to oxazolidinones in MDR Staphylococcus epidermidis clinical isolates in a tertiary care hospital in France Dortet, Laurent Glaser, Philippe Kassis-Chikhani, Najiby Girlich, Delphine Ichai, Philippe Boudon, Marc Samuel, Didier Creton, Elodie Imanci, Dilek Bonnin, Rémy Fortineau, Nicolas Naas, Thierry J Antimicrob Chemother Original Research OBJECTIVES: Patient- and procedure-related changes in modern medicine have turned CoNS into one of the major nosocomial pathogens. Treatments of CoNS infections are challenging owing to the large proportion of MDR strains and oxazolidinones often remain the last active antimicrobial molecules. Here, we have investigated a long-lasting outbreak (2010–13) due to methicillin- and linezolid-resistant (LR) CoNS (n = 168), involving 72 carriers and 49 infected patients. METHODS: Antimicrobial susceptibilities were tested by the disc diffusion method and MICs were determined by broth microdilution or Etest. The clonal relationship of LR Staphylococcus epidermidis (LRSE) was first determined using a semi-automated repetitive element palindromic PCR (rep-PCR) method. Then, WGS was performed on all cfr-positive LRSE (n = 30) and LRSE isolates representative of each rep-PCR-defined clone (n = 17). Self-transferability of cfr-carrying plasmids was analysed by filter-mating experiments. RESULTS: This outbreak was caused by the dissemination of three clones (ST2, ST5 and ST22) of LRSE. In these clones, linezolid resistance was caused by (i) mutations in the chromosome-located genes encoding the 23S RNA and L3 and L4 ribosomal proteins, but also by (ii) the dissemination of two different self-conjugative plasmids carrying the cfr gene encoding a 23S RNA methylase. By monitoring linezolid prescriptions in two neighbouring hospitals, we highlighted that the spread of LR-CoNS was strongly associated with linezolid use. CONCLUSIONS: Physicians should be aware that plasmid-encoded linezolid resistance has started to disseminate among CoNS and that rational use of oxazolidinones is critical to preserve these molecules as efficient treatment options for MDR Gram-positive pathogens. Oxford University Press 2018-01 2017-10-30 /pmc/articles/PMC5890688/ /pubmed/29092052 http://dx.doi.org/10.1093/jac/dkx370 Text en © The Author 2017. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy. http://creativecommons.org/licenses/by-nc/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com.
spellingShingle Original Research
Dortet, Laurent
Glaser, Philippe
Kassis-Chikhani, Najiby
Girlich, Delphine
Ichai, Philippe
Boudon, Marc
Samuel, Didier
Creton, Elodie
Imanci, Dilek
Bonnin, Rémy
Fortineau, Nicolas
Naas, Thierry
Long-lasting successful dissemination of resistance to oxazolidinones in MDR Staphylococcus epidermidis clinical isolates in a tertiary care hospital in France
title Long-lasting successful dissemination of resistance to oxazolidinones in MDR Staphylococcus epidermidis clinical isolates in a tertiary care hospital in France
title_full Long-lasting successful dissemination of resistance to oxazolidinones in MDR Staphylococcus epidermidis clinical isolates in a tertiary care hospital in France
title_fullStr Long-lasting successful dissemination of resistance to oxazolidinones in MDR Staphylococcus epidermidis clinical isolates in a tertiary care hospital in France
title_full_unstemmed Long-lasting successful dissemination of resistance to oxazolidinones in MDR Staphylococcus epidermidis clinical isolates in a tertiary care hospital in France
title_short Long-lasting successful dissemination of resistance to oxazolidinones in MDR Staphylococcus epidermidis clinical isolates in a tertiary care hospital in France
title_sort long-lasting successful dissemination of resistance to oxazolidinones in mdr staphylococcus epidermidis clinical isolates in a tertiary care hospital in france
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5890688/
https://www.ncbi.nlm.nih.gov/pubmed/29092052
http://dx.doi.org/10.1093/jac/dkx370
work_keys_str_mv AT dortetlaurent longlastingsuccessfuldisseminationofresistancetooxazolidinonesinmdrstaphylococcusepidermidisclinicalisolatesinatertiarycarehospitalinfrance
AT glaserphilippe longlastingsuccessfuldisseminationofresistancetooxazolidinonesinmdrstaphylococcusepidermidisclinicalisolatesinatertiarycarehospitalinfrance
AT kassischikhaninajiby longlastingsuccessfuldisseminationofresistancetooxazolidinonesinmdrstaphylococcusepidermidisclinicalisolatesinatertiarycarehospitalinfrance
AT girlichdelphine longlastingsuccessfuldisseminationofresistancetooxazolidinonesinmdrstaphylococcusepidermidisclinicalisolatesinatertiarycarehospitalinfrance
AT ichaiphilippe longlastingsuccessfuldisseminationofresistancetooxazolidinonesinmdrstaphylococcusepidermidisclinicalisolatesinatertiarycarehospitalinfrance
AT boudonmarc longlastingsuccessfuldisseminationofresistancetooxazolidinonesinmdrstaphylococcusepidermidisclinicalisolatesinatertiarycarehospitalinfrance
AT samueldidier longlastingsuccessfuldisseminationofresistancetooxazolidinonesinmdrstaphylococcusepidermidisclinicalisolatesinatertiarycarehospitalinfrance
AT cretonelodie longlastingsuccessfuldisseminationofresistancetooxazolidinonesinmdrstaphylococcusepidermidisclinicalisolatesinatertiarycarehospitalinfrance
AT imancidilek longlastingsuccessfuldisseminationofresistancetooxazolidinonesinmdrstaphylococcusepidermidisclinicalisolatesinatertiarycarehospitalinfrance
AT bonninremy longlastingsuccessfuldisseminationofresistancetooxazolidinonesinmdrstaphylococcusepidermidisclinicalisolatesinatertiarycarehospitalinfrance
AT fortineaunicolas longlastingsuccessfuldisseminationofresistancetooxazolidinonesinmdrstaphylococcusepidermidisclinicalisolatesinatertiarycarehospitalinfrance
AT naasthierry longlastingsuccessfuldisseminationofresistancetooxazolidinonesinmdrstaphylococcusepidermidisclinicalisolatesinatertiarycarehospitalinfrance